• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.0MM X 30MM - IDE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK SURPASS EVOLVE 4.0MM X 30MM - IDE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Catalog Number FDC40030
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Thromboembolism (2654); Speech Disorder (4415)
Event Date 09/28/2022
Event Type  Injury  
Event Description
It was reported that one day post procedure for left posterior communicating artery with the subject flow diverter, the patient had aphasia adjudicated as a minor stroke ischemic ipsilateral.Mri revealed multiple signs of recent ischemic stroke in the frontal and left parieto-occipital region, in connection with thromboembolic accidents per procedure.There was no device deficiency reported.The study device was implanted successfully, completely covering the neck in conjunction with a previously implanted device (coiling was performed in (b)(6) 2022).According to site this adverse event is not related to the subject flow diverter but according to cec members it had a causal relationship with the procedure and a possible relationship with the subject flow diverting stent and dapt (dual anti-platelet therapy).The adverse event was resolved without any treatment.No additional information available.
 
Manufacturer Narrative
H3 other text : the device remains implanted in the patient.
 
Event Description
It was reported that one day post procedure for left posterior communicating artery with the subject flow diverter, the patient had aphasia adjudicated as a minor stroke ischemic ipsilateral.Mri revealed multiple signs of recent ischemic stroke in the frontal and left parieto-occipital region, in connection with thromboembolic accidents per procedure.There was no device deficiency reported.The study device was implanted successfully, completely covering the neck in conjunction with a previously implanted device (coiling was performed in (b)(6) 2022).According to site this adverse event is not related to the subject flow diverter but according to cec members it had a causal relationship with the procedure and a possible relationship with the subject flow diverting stent and dapt (dual anti-platelet therapy).The adverse event was resolved without any treatment.No additional information available.
 
Manufacturer Narrative
H4 manufacturing date ¿ added, d4 expiration date - added, d4 lot # - corrected from 22312218 to 22312218r.Due to the automated mes (manufacturing execution system) system there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device was not available; therefore, a visual inspection as well as a functional evaluation could not be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Additional information provided by the customer indicated there was no medical intervention.The surgery start time: 8:04; end time: 11h16.The patient¿s mrs score=0.There was no device deficiency reported.The study device was implanted successfully, completely covering the neck in conjunction with a previously implanted device (coiling was performed in (b)(6) 2022).The site reported the adverse event as not related to the study device but the cec (clinical events committee) members considered the adverse event was possibly related to the study device.An assignable cause of anticipated procedural complication will be assigned to the reported event as a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURPASS EVOLVE 4.0MM X 30MM - IDE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key17123389
MDR Text Key317113359
Report Number3008881809-2023-00299
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P170024/S003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/07/2023
Device Catalogue NumberFDC40030
Device Lot Number22312218R
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/09/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/08/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
7 RX COIL KA (NON-STRYKER)
Patient Outcome(s) Other;
Patient Age43 YR
Patient SexMale
-
-